publication venue for
- COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case-control study.. 15. 2022
- Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer.. 13. 2020
- Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials.. 12. 2019
- Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.. 9. 2016
- Daytime intragastric acid control: post hoc analyses of esomeprazole 20 mg and over-the-counter proton-pump inhibitors.. 8. 2015
- The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial).. 8. 2015
- Low vitamin D level is an independent predictor of poor outcomes in Clostridium difficile-associated diarrhea.. 7. 2014
- Pillcam ESO(®) is more accurate than clinical scoring systems in risk stratifying emergency room patients with acute upper gastrointestinal bleeding.. 6. 2013
- The role of pembrolizumab in the treatment of PD-L1 expressing gastric and gastroesophageal junction adenocarcinoma. 2019
- Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. 2016
- Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? 2016
- The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease. 2016